Results 171 to 173 of about 3,564 (173)

Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials

SAGE Open Medicine
Rong He, Fei Lin
exaly  

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3 Open-Label Extension Study

American Journal of Respiratory and Critical Care Medicine
Hiran Selvadurai, Bonnie Ramsey
exaly  

Nasal Epithelium Transcriptomics Predict Clinical Response to Elexacaftor/Tezacaftor/Ivacaftor

American Journal of Respiratory Cell and Molecular Biology
Daniel J Weiner, Franziska Rosser, Joseph M․ Pilewski   +2 more
exaly